Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Bill of Health
APRIL 7, 2023
Research centers and companies that received government funds are typically allowed to manage their contractual and licensing terms independently with their commercial partners. Shamnad Basheer, a stalwart Indian IP lawyer, proposed in 2012 an ‘investment protection regime’ for innovation that fits well in the mRNA context.
Let's personalize your content